Pasqal Computing is moving forward with its SPAC combination while simultaneously raising a dedicated European fund, a dual-track structure that places the Paris-based quantum computing firm at the center of transatlantic capital allocation. The company is targeting €50 million for the European vehicle, according to filings reviewed alongside the SPAC disclosure. The merger with a blank-check entity gives Pasqal access to U.S. public markets while the European fund anchors manufacturing and research operations in France and Germany.
Pasqal builds neutral-atom quantum processors, a physical approach distinct from the superconducting qubits used by IBM and Google. The technology operates at room temperature, reducing infrastructure costs but requiring different error-correction protocols. The SPAC structure provides immediate liquidity and a Nasdaq listing, while the European fund isolates sovereign-sensitive R&D from U.S. disclosure requirements. The company has not disclosed redemption rates or the identity of the SPAC sponsor, but the dual-raise model suggests institutional appetite for quantum hardware remains concentrated among family offices and sovereign wealth funds rather than crossover public equity desks.
The structure matters because it reflects a broader pattern in deep-tech financing: companies with long development cycles and government contracts are bifurcating their capital bases by geography. Pasqal has existing relationships with the French Atomic Energy Commission and Germany's Forschungszentrum Jülich, contracts that carry technology-transfer restrictions and procurement preferences favoring European entities. The European fund allows those relationships to remain within a clean legal structure while the SPAC provides currency for U.S. partnerships and employee equity. The model mirrors what Airbus and Thales have done in defense, where dual-entity structures keep sovereign work ring-fenced.
Allocators should watch for three specific developments over the next six months. First, whether the SPAC redemption rate exceeds 40 percent, which would signal that public-market investors remain skeptical of pre-revenue quantum plays regardless of technical differentiation. Second, the composition of the European fund's limited partner base—if it skews toward industrial corporates like Atos or Siemens rather than pure financial sponsors, that indicates a procurement-driven thesis rather than a technology-risk bet. Third, any disclosure around Pasqal's error rates and qubit coherence times relative to superconducting competitors, which will determine whether neutral-atom systems can address commercially relevant optimization problems within the next eighteen months.
The SPAC filing contains minimal financial guidance, but the European fund's target size implies Pasqal is valuing its continental operations at a €200 million to €300 million run rate, assuming a standard 20 to 25 percent equity raise for growth-stage hardware companies. That valuation sits below the €500 million to €1 billion range where superconducting quantum firms have traded in private rounds, reflecting both Pasqal's earlier commercial stage and investor uncertainty around neutral-atom scalability. The European fund closes in Q2 2025, per the timeline embedded in the SPAC proxy.